Medications

Combined therapy makes headway for liver cancer

A drug that targets a protein known as phosphatidylserine boosted the response rate for hepatocellular carcinoma (HCC) patients receiving immunotherapy without compromising their safety, according to results of a phase two ...

Addiction

Q&A: Pandemic policies linked to overdose spike

Drug overdose rates skyrocketed in the United States during the first year of the COVID-19 pandemic. According to the National Institutes of Health, more than 92,000 people died due to overdose in 2020. Public health experts ...